Navidea Biopharmaceuticals News

Navidea Biopharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John K. Scott, Jr.(61.8%)

Feb 5 19:54 ET

Navidea Biopharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John K. Scott, Jr.(61.8%)

Dec 21, 2023 15:32 ET

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scott John K Jr.

Dec 5, 2023 18:26 ET

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Moss Dana J

Nov 20, 2023 18:43 ET

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Stefanelli Jill

Nov 20, 2023 18:10 ET

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-CHIEF FINANCIAL OFFICER Dais Craig

Nov 14, 2023 16:38 ET

Navidea Biopharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Dais Craig

Aug 15, 2023 17:53 ET

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Moss Dana J

Jul 17, 2023 18:02 ET

Navidea Biopharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Moss Dana J

Jul 17, 2023 18:00 ET

Navidea Biopharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John K. Scott, Jr.(75.04%)

Jul 3, 2023 18:39 ET

Navidea Biopharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Irwin Bain(4.73%)

Jul 3, 2023 16:01 ET

Navidea Biopharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Irwin Bain(4.73%)

Jun 30, 2023 16:01 ET

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scott John K Jr.

Jun 30, 2023 10:46 ET

Navidea Biopharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John K. Scott, Jr.(52.85%)

Jun 16, 2023 16:20 ET

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scott John K Jr.

Jun 15, 2023 18:35 ET

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Stefanelli Jill

Jun 12, 2023 11:03 ET

Navidea Biopharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Stefanelli Jill

Jun 9, 2023 14:41 ET

Navidea Biopharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Witter Malcolm G

Nov 30, 2022 19:27 ET

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Nov 30, 2022 16:13 ET

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Nov 30, 2022 16:12 ET